Publication: In vitro metabolism, reaction phenotyping, enzyme kinetics, cytochrome P450 (CYP) inhibition and induction potential of ataluren
This research article, published inPharmacology Research and Perspectives,describes the in vitro metabolism and enzyme kinetics of ataluren and its interaction with CYP enzymes
The disposition and metabolism of ataluren in vitro is described
The data relating to the enzyme kinetics of ataluren and its interaction with CYP enzymes is presented
Once registered, you will be able to view the abstract and be provided the DOI and PubMed links for this publication.
Kong R, Ma J, Hwang S, et al. Pharmacol Res Perspect. 2020;8(2):e00576
▼ Ataluren is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system. Adverse events should also be reported to PTC at email@example.com.
Registration conditions differ internationally, and prescribing information may vary depending on local approval in each country. The European Summary of Product Characteristics for ataluren is available here. Please refer to your local country guidance for more information.
Register now to unlock the content
Register now to access the content on this page
If not, register below
GL-DMD-0442 | October 2021
Sign in or register to access exclusive content on this site
Some cookies are essential, others help us improve your experience by providing insights into how the website is used. Select one or more of the cookie types listed below, and then save your preferences. Refer to our Cookies Statement for more information.
Performance cookies, which help us measure the website’s performance and improve your experience. In using performance cookies we do not store any personal data, and only use the information collected through these cookies in aggregated and anonymised form.